Clinical Study

A Randomized Phase III Trial Evaluating The Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (Ct1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Posted Date: Jun 29, 2014

  • Investigator: Elizabeth Shaughnessy
  • Co-Investigator: Erica Christensen
  • Specialties: Hematology/Oncology, Oncology, Radiation Oncology, Surgical Oncology, Breast Cancer, Cancer
  • Type of Study: Drug

The purpose of this study is to examine whether removing some of the lymph nodes from the arm pit, but not removing them all followed with radiation therapy (experimental) will be as good as having the majority of the lymph nodes from the arm pit removed during breast surgery followed with radiation (standard of care).

Criteria:

To Qualify You Must Have Breast Cancer That Has Spread To The Lymph Nodes Under Your Arm (In The Arm Pit) And You Have Been Treated With Chemotherapy Before Having Surgery To Remove Any Remaining Breast Cancer.

Keywords:

A011202, Axillary Lymph Node Dissection, Breast Cancer, Ct1-3 N1, Positive Sentinel Lymph Node Disease

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.